Clinician and payer insight regarding complexities managing patients with chronic kidney disease and type 2 diabetes, and best practices utilizing newer treatment options.
EP. 1: Characteristics of Chronic Kidney DiseaseSeptember 30th 2021
Drs Rajiv Agarwal and Eugene Wright Jr. highlight risk factors associated with chronic kidney disease and react to concerns surrounding the assessment and treatment of patients.
EP. 4: Clinical and Economic Burden of Chronic Kidney DiseaseOctober 7th 2021
Financial and clinical concerns surrounding the burden of chronic kidney disease progression, as well as social determinants that factor into managing the condition in the community.
EP. 6: Motivating Patients Who Have CKD and T2DMOctober 14th 2021
Strategies that can help clinicians establish and work toward goals when treating patients with chronic kidney disease to help control disease and prevent progression.
EP. 7: Care Coordination for Patients With CKD and T2DMOctober 21st 2021
Various types of health care professionals who may play a role in treating patients with chronic kidney disease, and recommendations to help overcome barriers that impact risk of disease progression and outcomes for patients.
EP. 9: Early Identification and Management of CKDOctober 28th 2021
What better testing strategies and newer quality measures can do to improve patient referrals to nephrologists for earlier intervention of chronic kidney disease.
EP. 13: Non-steroidal MRAs for Chronic Kidney DiseaseNovember 11th 2021
What to know in terms of the mechanism of action of non-steroidal MRA finerenone compared with other therapies used to treat patients with chronic kidney disease and type 2 diabetes.
EP. 16: Emerging Therapies for Chronic Kidney DiseaseNovember 15th 2021
An overview of therapies in the pipeline, including other nonsteroidal MRAs, that show potential in treating patients who have chronic kidney disease and type 2 diabetes.
EP. 17: Optimizing Outcomes for Patients With CKD and T2DMNovember 15th 2021
Steps that need to be taken to address unmet needs and optimize outcomes for patients who have chronic kidney disease and type 2 diabetes.